Volume 4, Issue 3, Pages (April 2018)

Slides:



Advertisements
Similar presentations
Brett R. Barlow, BS, Ryan V. Marshall, BS, MS, John David Wofford, MD 
Advertisements

Jeff Donovan, MD, PhD, FRCPC  JAAD Case Reports 
Volume 3, Issue 6, Pages (November 2017)
Volume 4, Issue 1, Pages (January 2018)
Leprosy mimicking basal cell carcinoma in a patient on fingolimod
Facial pilomatrix carcinomas treated with Mohs micrographic surgery
Volume 3, Issue 3, Pages (May 2017)
Volume 4, Issue 3, Pages (April 2018)
Expression of PD-L1 in mastocytosis
Hemorrhagic lesion on the chest wall after trauma
Volume 1, Issue 5, Pages (September 2015)
Exploring the relationship between natural killer cells and cutaneous squamous cell carcinoma development  Muneeb Ilyas, BSc, Collin M. Costello, BS,
Cynthia M. Magro, MD, Tracy L. Davis, MD, PhD, Drew J.B. Kurtzman, MD 
Volume 1, Issue 5, Pages (September 2015)
Removal of forearm lentigines in dyschromatosis universalis hereditaria with a 755-nm Q-switched alexandrite laser  Yiming Li, MD, PhD, Li Li, MD, PhD 
An enlarging, ulcerated scalp nodule
Volume 3, Issue 5, Pages (September 2017)
Digital metastasis of tongue squamous cell carcinoma
Volume 3, Issue 1, Pages (January 2017)
Volume 3, Issue 6, Pages (November 2017)
Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor  Gabriela M. Morris, BS, Zachary P. Nahmias,
Incidental regression of an advanced basal cell carcinoma after ipilimumab exposure for metastatic melanoma  Shalini V. Mohan, MD, Karen Y. Kuo, MD, Anne.
Volume 2, Issue 6, Pages (November 2016)
Romidepsin-induced neutrophilic urticaria
A rare case of super giant basal cell carcinoma
Scott M. Peters, DDS, Louis Mandel, DDS, Michael A. Perrino, DDS, MD 
Volume 3, Issue 6, Pages (November 2017)
Mark D. Heibel, MD, Haley D. Heibel, MS  JAAD Case Reports 
Two cases of maggot debridement therapy in pyoderma gangrenosum
Volume 4, Issue 7, Pages (August 2018)
Ken Shiraishi, MD, PhD, Koji Sayama, MD, PhD  JAAD Case Reports 
Volume 4, Issue 1, Pages (January 2018)
Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD  JAAD Case Reports 
Nicole Maillet-Lebel, MD, Marie-Marthe Thibeault, MD, FRCPC 
Volume 4, Issue 6, Pages (July 2018)
Volume 1, Issue 1, Pages 7-8 (January 2015)
Spectrum and progression of disease from condyloma to aggressive anogenital squamous cell carcinoma in 3 HIV-positive patients  Olaf Rodriguez, BS, Carrie.
Recurrent breast cellulitis from a nipple fissure
Diffuse pruritic papules
Nader Aboul-Fettouh, BS, Rajiv I. Nijhawan, MD  JAAD Case Reports 
Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases
Volume 4, Issue 6, Pages (July 2018)
An atypical presentation of a rare disease
Andrew D. Breithaupt, MD, David Beynet, MD, Teresa Soriano, MD 
Hemorrhagic bullae of the oral mucosa
Spiny keratoderma exposes underlying renal cell carcinoma
Slowly progressive chest rash in an elderly woman
Divalproex sodium: A potential therapy for scleroderma digital ulcers
Papules developing in an old tattoo
Volume 1, Issue 6, Pages (November 2015)
Volume 5, Issue 4, Pages (April 2019)
Olga Vornicova, MD, Gil Bar-Sela, MD  JAAD Case Reports 
Recalcitrant prurigo nodularis treated successfully with dupilumab
Heidrun Mitzel, MD, Stephan Grabbe, MD, Carmen Loquai, MD 
Painful violaceus bullae of the hands
Volume 5, Issue 3, Pages (March 2019)
Identification of novel targetable mutations in metastatic anorectal melanoma by next- generation sequencing  Emily D. Cai, BA, Jinah Kim, MD, PhD  JAAD.
Widespread hyperpigmented rash present for 1 year
Spontaneous resolution of advanced basal cell carcinoma after short-pulse treatment with hedgehog pathway inhibitor  Audrey A. Jacobsen, BA, John Strasswimmer,
Multisystemic Langerhans cell histiocytosis in an adult
Pembrolizumab-induced bullous pemphigoid
Lip ulceration in an immunocompromised patient
Volume 3, Issue 6, Pages (November 2017)
Volume 4, Issue 1, Pages (January 2018)
Bryan Baillis, MD, John C. Maize, MD  JAAD Case Reports 
Tattoo pigment removal by halo nevus phenomenon
Morphea in a patient undergoing treatment with ustekinumab
Delayed treatment of endocrine mucin–producing sweat gland carcinoma initially diagnosed as a chalazion  Orr A. Meltzer, BS, Jeffrey M. Joseph, MD  JAAD.
Volume 5, Issue 7, Pages (July 2019)
Volume 2, Issue 3, Pages (May 2016)
Presentation transcript:

Volume 4, Issue 3, Pages 248-250 (April 2018) A case of metastatic basal cell carcinoma treated with continuous PD-1 inhibitor exposure even after subsequent initiation of radiotherapy and surgery  John G.D. Cannon, BS, Jeffery S. Russell, MD, Jinah Kim, MD, PhD, Anne Lynn S. Chang, MD  JAAD Case Reports  Volume 4, Issue 3, Pages 248-250 (April 2018) DOI: 10.1016/j.jdcr.2018.01.015 Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Immunohistochemical and radiographic findings in a patient with metastatic BCC treated with pembrolizumab overlapping with radiotherapy and surgery. A, Significant PD-L1 expression in the recurrent shoulder BCC (arrow) and peritumoral infiltrate (double arrow) using mouse anti–PD-L1 monoclonal antibody, clone 2B11D11, Proteintech). (Original magnification: ×200.) B, CT image of pulmonary metastases with arrow indicating example lesion before pembrolizumab (red arrow). C, After 6 weeks of pembrolizumab, this lesion completely resolved (red arrow). JAAD Case Reports 2018 4, 248-250DOI: (10.1016/j.jdcr.2018.01.015) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions